Quantum Biopharma Ltd. Files March 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Mar 31, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Quantum Biopharma (fka FSD Pharma) filed its March 2025 6-K, standard foreign issuer report.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on March 31, 2025, reporting for the month of March 2025. The company, incorporated in A6 with its principal executive office in Toronto, Canada, is in the Pharmaceutical Preparations industry. It previously changed its name from FSD Pharma Inc. on March 27, 2019.
Why It Matters
This filing provides routine updates for Quantum Biopharma Ltd. as a foreign private issuer, indicating its ongoing compliance with SEC reporting requirements.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- March 31, 2025 (date) — Report date
- Toronto, Ontario (location) — Principal executive office location
FAQ
What is the primary business of Quantum Biopharma Ltd.?
Quantum Biopharma Ltd. is in the Pharmaceutical Preparations industry, SIC code 2834.
When did Quantum Biopharma Ltd. change its name from FSD Pharma Inc.?
The company changed its name from FSD Pharma Inc. on March 27, 2019.
What is the filing date of this Form 6-K?
This Form 6-K was filed as of March 31, 2025.
Does Quantum Biopharma Ltd. file annual reports under Form 20-F or 40-F?
Quantum Biopharma Ltd. indicates it files annual reports under Form 20-F.
Where are Quantum Biopharma Ltd.'s principal executive offices located?
The principal executive offices are located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 31, 2025 regarding Quantum Biopharma Ltd. (QNTM).